{
  "docId": "019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "docSlug": "c76f9a1cfbf11e27618f62d901587aa3",
  "documentTitle": "Alkermes | Results Presentation Deck | 22 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 22,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a structured table format to detail the next steps across five key dimensions: Timing, Financial Expectations, Leadership, Location, and Closing Conditions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-e60e-740c-a4d1-b8dd6fcd421d/9",
  "deckHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "deckJsonHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d.json",
  "deckAnchorHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "‡ Assuming separation is effected through a spin-off of the oncology business into an independent, publicly-traded company",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be8bd31a-04b8-4c03-be6b-d68491cb01cf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "table",
      "text": "Timing: Separation expected H2 2023. Financial: Expenses expected, 2023 targets in Feb call. Leadership: Oncology Co. details later, Alkermes CEO remains. Location: Oncology Co. in Waltham, Alkermes in Wilmington/Athlone. Closing: Board approval.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "baf53383-3175-4818-b147-220d7c5d09d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "Potential Separation‡: Next Steps",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06f0a557-d9ba-4d48-965b-aeeb8bae85d9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "breakup-spinoff",
      "slug": null,
      "matchId": "35262a50-11b0-4fd5-8d01-f7ea17dfb938",
      "evidence": "The slide explicitly discusses the next steps for a potential spin-off of the oncology business.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 6,
      "beatId": "447f6264-8955-4168-914e-cfe1363597e7",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document proposes a solution (separation of oncology business) and presents expected outcomes to satisfy the audience's needs.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 6,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "a5a157cc-9029-478a-92e9-6838ab291f2a",
      "evidence": "The document presents a clear pattern of benefits, including enhanced profitability and clear value propositions.",
      "position": 0,
      "objective": "What are the benefits of separating the oncology business?",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    },
    {
      "to": 10,
      "from": 9,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "2176885d-9684-437b-9f12-0be3d9ec6957",
      "evidence": "The document presents next steps and a roadmap for separation.",
      "position": 1,
      "objective": "Why is now the right time for separation?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}